Zsolt Timar
The international journal, Pathology Oncology Research (PORE), established in 1995 by the founding Editors, László Kopper, Judit Nagy, Zsolt Orosz and József Tímár. The aim of launching PORE was to promote pathological and oncological publishing activity of scientists in Central and East Europe. Those were the years when the 200 year old conservative science, histopathology, began to transform into a „rocket science” discipline with the development of molecular pathology. These developments affected the every day routine of diagnostic pathology but fundamentally affected also the clinical practice as well. Major beneficiary of that transformation was medical oncology. As the Founding Editors were active participants of these changes the profile of the new Journal was unquestionable. The owner and founder of PORE is the Arányi Lajos Foundation for Modern Pathology. The Foundation is named after Lajos Arányi (1812-1887), the founding father of the first pathology department in Hungary back to 1844 at the Medical Faculty of Pazmany University, Budapest (est. 1769, today Semmelweis University). This was the 5th Department after Vienna, Edinburgh, Strasburg and Paris. Arányi was the author of the first Hungarian textbook of pathology (1864) and his research included edema, narcosis and suffocation. Arányi’s idea of complementary private support for state-financed medical institutions was revitalized by the founders of Arányi Lajos Foundation who became the founders of the new Journal as well.
Zsolt is a very competent plant designer with a good depth of technical and manegerial knowledge. Zsolt has an excellent working relationship with everyone on the project and is well appreciated. View Zsolt Timar’s profile on LinkedIn, the world’s largest professional community. Zsolt has 2 jobs listed on their profile. See the complete profile on LinkedIn and discover Zsolt’s connections and jobs at similar companies.
The lunch of the new journal happened in 1995 with one issue [1] and the first complete publishing year was 1996 with 4 issues containing 24 original articles, 7 reviews and 7 case reports. Starting as a PubMed-referred Journal, obtained an international reputation backed by the publisher Saunders (Elsevier) for years. PORE received its first impact factor in 2004 when was run independently by the Foundation. From 2007 the publisher of PORE is Springer (later on the Springer-Nature group) the help of which PORE outgrown as a really international translational science Journal still run by its founding editors, László Kopper and József Tímár and an International Editorial Board but still with a significant presence of the Semmelweis Faculties. Till today PORE published appr. 2300 articles for those appr. 2100 citations can be found in the biomedical literature and the yearly usage of the Journal’s articles passed 105 downloads. Equally important is that the latest Thompson-Reuters impact factor of PORE is now 2.44 ranked 56th among 202 Pathology titles and 183rd among 368 Oncology titles according to Scimago SJR. As compared to the first volume in 1995-96, in the 2019/volume 25, PORE published 4 reviews, 219 original articles, 2 Short Communications and 7 Letters. The number of yearly submissions passed 1000 with an acceptance rate of 25%. PORE reached its adult age but still has a growing potential if can accomodate to the changing scientific publishing environment.
Reference
- 1.
Kopper L (1995) Prologue. Pathol Oncol Res 1:6
Author information
Affiliations
Corresponding authors
Correspondence to L. Kopper or J. Tímár.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kopper, L., Tímár, J. 25th Anniversary of Pathology Oncology Research. Pathol. Oncol. Res.26, 1 (2020). https://doi.org/10.1007/s12253-020-00795-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-020-00795-2
EDITORS-IN-CHIEF
László Kopper, Semmelweis University, Budapest, Hungary
József Tímár, Semmelweis University, Budapest, Hungary
FOUNDING EDITORS
Zsolt Orosz, Oxford University Hospitals, Oxford, UK
Judit Nagy, Professional Publishing Hungary Co., Budapest, Hungary
MANAGING EDITOR
Anna Sebestyén, Semmelweis University, Budapest, Hungary
EDITORIAL CONSULTANT
Andrea Ladányi, National Institute of Oncology, Budapest, Hungary
EDITORIAL ADVISORY BOARD
Adriana Albini,IRCCS Multimedica, Milano, Italy
Zsolt Argényi,University of Washington, Seattle, Washington, USA
Mikael Björkstedt,Karolinska Institute, Stockholm, Sweden
Zsolt Timar
Fred Bosman,University of Lausanne, Switzerland
Gábor Cserni, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary
Helmut Denk,University of Graz, Austria
Mary JC Hendrix, Shepherd University, Shepherdtown, WVA, USA
Kenneth V. Honn,Wayne State University, Detroit, MI, USA
Sirpa Jalkanen, University of Turku, Finnland
András Jeney,Semmelweis University, Budapest, Hungary
Andras Khoor,Mayo Clinic, Jacksonville, FL, USA
Ilona Kovalszky,Semmelweis University, Budapest, Hungary
Tibor Krenács, Semmelweis University, Budapest, Hungary
Thomas Krausz,The University of Chicago, Chicago, Illinois, USA
Janina Kulka,Semmelweis University, Budapest, Hungary
Károly Lapis,Semmelweis University, Budapest, Hungary
András Matolcsy,Semmelweis University, Budapest, Hungary
Dr Timar Zsolt
Yukio Nishimura,Kyushu University, Fukuoka, Japan
Robert Pirker, University of Vienna, Austria
Helmuth Popper, University of Graz, Austria
Lajos Pusztai, The University of Texas MD Anderson Cancer Center, Houston TX, USA
Avraham Raz, Michigan Cancer Foundation, Detroit, MI, USA
Ales Ryska, Charles University, Hradec Kralove, Czech Republic
Timar Zsolt
Zoltán Sápi, Semmelweis University, Budapest, Hungary
Zsuzsa Schaff,Semmelweis University, Budapest, Hungary
Péter Sótonyi, Semmelweis University, Budapest, Hungary
Zoltan Szallasi, Boston Children’s Hospital, Dana-Farber/Harvard Cancer Center, Boston, MA, USA
Béla Szende,Semmelweis University, Budapest, Hungary